Hypertension and diabetes: should we treat early surrogates? What are the cons?

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S290-3. doi: 10.2337/dc09-S329.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Amlodipine / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / mortality
  • Clinical Trials as Topic
  • Diabetes Mellitus / physiopathology*
  • Diabetic Angiopathies / drug therapy
  • Diabetic Angiopathies / epidemiology*
  • Diabetic Angiopathies / mortality
  • Drug Therapy, Combination
  • Guidelines as Topic
  • Humans
  • Hypertension / drug therapy
  • Risk Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Amlodipine